Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,178 public trials 548 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

NCT01967940

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Midway Immunology and Research center Ft. Pierce, Florida, United States
  • Triple O Research Institute, P.A. West Palm Beach, Florida, United States
  • Rowan Tree Medical, P.A. Wilton Manors, Florida, United States
  • Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
View all 15 locations
View Trial Details
Completed

Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

NCT02300103

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • San Diego, California, United States
  • San Marcos, California, United States
  • Aurora, Colorado, United States
  • Gainesville, Florida, United States
View all 30 locations
View Trial Details
Completed

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

NCT02201953

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Sacramento, California, United States
  • San Diego, California, United States
View all 76 locations
View Trial Details
Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

NCT02073656

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • Newport Beach, California, United States
  • Palo Alto, California, United States
View all 41 locations
View Trial Details

Related conditions